Autor: |
Matthews WD, Intoccia AP, Osborne VL, McCafferty GP |
Jazyk: |
angličtina |
Zdroj: |
European journal of pharmacology [Eur J Pharmacol] 1981 Jan 29; Vol. 69 (3), pp. 249-54. |
DOI: |
10.1016/0014-2999(81)90470-2 |
Abstrakt: |
Muscimol, an in vivo and in vitro GABA agonist, has anticonvulsant activity against bicuculline-induced seizures when given systemically to rats. To determine whether parent compound or a metabolite possessed the anticonvulsant activity, experiments were performed with [14C]muscimol. Anticonvulsant activity was determined by the percent of animals protected against tonic forelimb extension induced by bicuculline. Brain and urine were analyzed for unchanged [14C]muscimol by thin-layer chromatography. The time course of anticonvulsant activity and [14C]muscimol concentration in brain after intravenous injection were similar. Peak brain concentration of [14C]muscimol and maximal protection against bicuculline-induced seizures occurred simultaneously. These data suggest that intravenously administered [14C]muscimol rapidly penetrates brain tissue and parent compound is responsible for antagonism of bicuculline-induced convulsions. |
Databáze: |
MEDLINE |
Externí odkaz: |
|